Explore evidence

90 %The HPV vaccination program in Rwanda achieved over 90% coverage for girls aged 12.

Rwandainfection à HPVAfrica CDCdocument of 52 observations

0.8 %The point-prevalence of eczema was 0.8% in Rwanda.

Rwandaeczemapublished 2012Journal of the European Academy of Dermatology and Venereology : JEADVeurope_pmcdocument of 10 observations

11 countriesSustained human-to-human mpox transmission was observed in 11 countries as of February 2025: DRC, Congo Republic, Central African Republic, Burundi, Kenya, Rwanda, Uganda, Zambia, Nigeria, Liberia, and Cote d’Ivoire.

Burundi · Kenya · Liberia · Nigeria · Ouganda · RDC · Rwanda · Zambiempoxobserved February 2025Africa CDCdocument of 110 observations

500 peopleRwanda vaccinated approximately 500 people in Africa’s first mpox vaccination campaign, launched on 17 September 2024.

Rwandampoxobserved 17 September 2024Africa CDCdocument of 147 observations

26.7 %The overall prevalence of schoolchildren with any skin disease was 26.7% in Rwanda.

Rwandaskin diseasepublished 2013International journal of dermatologyeurope_pmcdocument of 8 observations

22.7 %Skin infections accounted for 22.7% of skin disease in Rwanda.

Rwandaskin infectionpublished 2013International journal of dermatologyeurope_pmcdocument of 8 observations

12,220 childrenThe estimated sample size for parasite prevalence in the 2014–2015 Rwanda Demographic and Health Survey (DHS) was 12,220 children aged 0–4 years.

Rwandapaludismeobserved 2014-2015published 2017Malaria journaleurope_pmcdocument of 4 observations

Rwanda aims to achieve the 90-70-90 cervical cancer elimination targets by 2027.

Rwandacancer du col de l'utérusobserved 2027Africa CDCdocument of 52 observations

50 %La prévalence de la neuropathie chez les personnes vivant avec le VIH au Rwanda était de 50 % dans une étude cohorte et transversale populationnelle.

Rwandaneuropathie périphériqueobserved 2014HAL · Unilimdocument of 747 observations

308 casesIn Rwanda, there were 308 cholera cases and 0 deaths from March 2025 to July 2025.

Rwandacholéraobserved Mar 2025 – 31 July 2025Africa CDCdocument of 176 observations

0 deathsRwanda reported 0 cholera deaths, with the outbreak starting in March 2025.

Rwandacholéraobserved Mar 2025Africa CDCdocument of 176 observations

88 %In Rwanda, 88% of cholera cases were among children under 15 years old.

Rwandacholéraobserved Mar 2025 – 31 July 2025Africa CDCdocument of 176 observations

6,269 dosesAs of 27 January 2025, 6,269 mpox vaccine doses had been administered in Rwanda.

Rwandampoxobserved 27 January 2025Africa CDCdocument of 72 observations

308 casesRwanda reported 308 cholera cases and 0 deaths, with the outbreak starting in March 2025.

Rwandacholéraobserved Mar 2025Africa CDCdocument of 176 observations

90 %Rwanda is focusing on advancing efforts toward the 90% cervical cancer treatment target.

Rwandacancer du col de l'utérusAfrica CDCdocument of 52 observations

Five countries — DRC, Rwanda, Uganda, Central African Republic and Nigeria — are currently vaccinating against mpox.

Nigeria · Ouganda · RDC · Rwandampoxobserved January-February 2025Africa CDCdocument of 72 observations

500 peopleRwanda conducted a vaccination campaign in the last week of September 2024, vaccinating approximately 500 people.

Rwandampoxobserved last week of September 2024Africa CDCdocument of 147 observations

Five countries — DRC, Rwanda, Uganda, Central African Republic, and Nigeria — were vaccinating against mpox during January–February 2025.

Nigeria · Ouganda · RDC · Rwandampoxobserved January-February 2025Africa CDCdocument of 72 observations

59 %La prévalence de la neuropathie chez les personnes vivant avec le VIH au Rwanda était de 59 % en 2014.

RwandaVIH/sidaobserved 2014HAL · Unilimdocument of 747 observations

Rwanda had the second-lowest age-standardised prevalence of diabetes for men.

Rwandadiabète (non précisé)HAL · Unilimdocument of 79 observations

22 districtsHPV DNA testing was introduced in Rwanda in 2019 and extended screening to 22 of 30 districts.

Rwandainfection à HPVobserved 2019Africa CDCdocument of 52 observations

Burundi, Central African Republic, Congo, Democratic Republic of the Congo, Gabon, Kenya, Rwanda, and Uganda reported mpox cases belonging to Clade I.

Burundi · Gabon · Kenya · Ouganda · RDC · RwandaClade I · mpoxAfrica CDCdocument of 11 observations

3.2 %La prévalence du diabète gestationnel au Rwanda était de 3,2 %.

Rwandadiabète gestationnelHAL · Unilimdocument of 602 observations

70 %Rwanda is focusing on advancing efforts toward the 70% cervical cancer screening target.

Rwandacancer du col de l'utérusAfrica CDCdocument of 52 observations

18 casesGenomic analysis of samples from 18 cases of Marburg virus disease was conducted in Rwanda.

RwandaMarburg virus diseasepublished 2025Nature medicineeurope_pmcdocument of 4 observations